You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

September 18, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

FDA committee recommends approval for liraglutide as anti-obesity drug

Liraglutide 3 mg (Saxenda, Novo Nordisk) has been recommended by an FDA Advisory Committee to be approved for use in the treatment of obesity.
» Read the results from the phase 3 clinical trials

New drug approved by FDA for treatment of opioid-induced constipation

FDA has approved a new treatment option for opioid-induced constipation in adult patients with chronic noncancer pain.
» This new drug will be on the market the first half of 2015

ADVERTISEMENT

Idiopathic Pulmonary Fibrosis (IPF)

IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen. While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Read More.

Continuing Education

MTM essentials for anticoagulant management in cardiovascular disease

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacological properties, safety and efficacy, and risk/benefit profile for the various anticoagulant medications used in cardiovascular diseases.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT10-VXP89.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

[BLOG]: Medications are the new battlefield and pharmacists are the best "recon" agents

Medication reconciliation can be performed by any trained healthcare professional (ie, nurses, pharmacy technicians, physicians, etc.), however improved patient safety outcomes have been demonstrated when pharmacists perform this process. » See more

 

Related Articles

FDA approval given for new drug to treat obesity

Opioid use common among disabled workers enrolled in Medicare

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group